For the year ending 2025-12-31, LPCN has $17,005,612 in assets. $2,528,196 in debts. $5,205,842 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 5,205,842 | |||
| Marketable investment securities | 9,724,545 | |||
| Accrued interest income | 14,189 | |||
| License fee and royalties receivable | 1,145,390 | |||
| Prepaid and other current assets | 787,600 | |||
| Total current assets | 16,877,566 | |||
| Property and equipment, gross | 1,388,372 | |||
| Less accumulated depreciation | 1,284,079 | |||
| Property and equipment, net of accumulated depreciation of 1,284,079 and 1,223,297, respectively | 104,293 | |||
| Other assets | 23,753 | |||
| Total assets | 17,005,612 | |||
| Accounts payable | 971,822 | |||
| Accrued expenses | 1,236,374 | |||
| Deferred revenue | 320,000 | |||
| Total current liabilities | 2,528,196 | |||
| Total liabilities | 2,528,196 | |||
| Common stock, par value 0.0001 per share, 75,000,000 shares authorized 6,158,779 and 5,348,276 issued and 6,158,443 and 5,347,940 outstanding, respectively | 8,944 | |||
| Additional paid-in capital | 223,901,106 | |||
| Treasury stock at cost, 336 shares | 40,712 | |||
| Accumulated other comprehensive gain | 4,445 | |||
| Accumulated deficit | -209,396,367 | |||
| Total stockholders equity | 14,477,416 | |||
| Total liabilities and stockholders equity | 17,005,612 | |||
Lipocine Inc. (LPCN)
Lipocine Inc. (LPCN)